Glenmark finds cancer drug, gains to reflect in long term

Shares of Glenmark Pharmaceuticals rose nearly 2.5% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company’s financials is a long term story, analysts said.

March 31, 2011 / 13:21 IST

live

bselive
nselive

Volume

Todays L/H

Shares of Glenmark Pharmaceuticals rose nearly 3% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company

first published: Mar 31, 2011 11:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347